Master’s Student Project in RNA: The University of Salzburg (PLUS) is offering a master’s thesis project opportunity focusing on RNA editing in collaboration with WAVE life sciences (USA). This project aims to investigate the intracellular transport and therapeutic applications of oligonucleotides in diverse disease model cell systems. The successful candidate will work within an interdisciplinary scientific framework, exploring the translation of fundamental biology into therapeutic approaches.
|As soon as possible
|University of Salzburg, WAVE life sciences
Study Area: Biochemistry, Molecular Biology, RNA Therapeutics, Cellular Biology, Biomedical Research.
Scholarship Description: This master’s thesis project, conducted at the Paris-Lodron University of Salzburg (PLUS), involves researching RNA editing as part of a collaborative effort between PLUS in Austria and WAVE life sciences in the USA. The project aims to delve into the intracellular transport and therapeutic potential of oligonucleotides across various disease models. The work will utilize advanced molecular and cellular biology techniques, microscopy, and biochemistry to analyze and quantify oligonucleotide activities in cellular systems.
Eligibility: Prospective candidates should hold a Bachelor’s degree in Life Sciences, possess extensive knowledge in biochemistry and molecular biology, and demonstrate proficiency in the English language. Excellent organizational skills and a passion for contributing to the evolution of RNA therapeutics are essential.
- Motivation Letter
- Curriculum Vitae (CV)
- Copies of Highest Obtained Degree Certificates
How to Apply: Interested applicants are invited to submit their applications to email@example.com with firstname.lastname@example.org in CC. Applications should include a motivation letter, CV, and copies of their highest obtained degree certificates. The application deadline is until the position is filled.
Last Date: Applications will be accepted until the position is filled. Act promptly to seize this opportunity to contribute to cutting-edge research at the interface of basic science and therapeutic applications. For more details, contact: Univ. Prof. Dr. Nicole Meisner-Kober Professor of Chemical Biology and Biological Therapeutics Department of Biosciences University of Salzburg Billrothstrasse 11, 5020 Salzburg, Austria https://www.uni-salzburg.at/nicole.meisner-kober